SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+ and TMTG News. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

Trump Media & Technology Group is trending amid widespread outrage and intense debate following reports of a fatal shooting involving ICE agents and an American citizen in Minneapolis. Community discussions are sharply divided, with many condemning the incident as an execution of an unarmed individual and a blatant abuse of federal authority, while others defend ICE's actions, asserting the individual was armed and interfering with agents. This event is fueling broader conversations about government overreach, second amendment rights, and federal agency accountability, with some speculating about its impact on impending government funding decisions.

Cadrenal Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in developing novel therapy. It develops tecarfarin, a novel therapy with orphan drug indication, designed for the prevention of systemic thromboembolism of cardiac origin in patients with end-stage renal disease and atrial fibrillation. The company was founded by Quang X. Pham and Matthew K. Szot on January 25, 2022 and is headquartered in Ponte Vedra, FL.

Cadrenal Therapeutics Inc

Cadrenal Therapeutics, Inc.

Cadrenal Therapeutics (CVKD) is trending amid discussions surrounding recent advancements in its cardiovascular drug pipeline, notably progress with tecarfarin manufacturing and the acquisition of VLX-1005 for heparin-induced thrombocytopenia. The community is sharply divided, with some investors bullish on its novel anticoagulants, FDA Fast Track designation, and strategic collaborations, while a skeptical contingent points to historical performance and concerns over recurring funding needs. Traders are closely watching its ultra-low float for potential volatility, balancing a perceived significant market opportunity against ongoing financial uncertainties.

Ocular Therapeutix, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapies for diseases and conditions of the eye. Its product pipeline includes Dextenza, OTX-TP, and OTX-TIC. The company was founded by Amarpreet S. Sawhney and Farhad Khosravi on September 12, 2006 and is headquartered in Bedford, MA.

Ocular Therapeutix Inc

Ocular Therapeutix is currently trending due to intense speculation surrounding an improved acquisition offer from Sanofi, following reports of a rejected $16/share bid. The community is highly optimistic about upcoming Phase 3 data for AXPAXLI in wet AMD, especially given the company's accelerated NDA strategy and the recent high-profile hire of a former Eylea architect. Investors are actively discussing the potential of AXPAXLI to redefine long-acting retinal therapy, fueling expectations for a substantial premium or strong independent commercialization, making it a focal point of market interest.

Zoracles

Zoracles ($ZORA) is actively discussed amid anticipation for the "Clarity Act" and broader crypto market bullishness, fueled by expected FED rate cuts and increased adoption. The community is keenly focused on Zora's utility as a creator-focused protocol within the Coinbase Base app, with many users "buying the dips" and holding for potential long-term gains. Despite some frustration over past stagnation and concerns about market manipulation, investors are looking for a significant reversal as regulatory clarity and liquidity are expected to boost the altcoin sector.

Global X Funds - Global X Copper Miners ETF

Global X Copper Miners ETF ($COPX) is trending amid discussions about anticipated widespread copper shortages driven by escalating demand from AI, electric vehicles, and global infrastructure development. Recent policy shifts, particularly around tariffs, have further intensified supply concerns, sparking bullish sentiment among investors who view copper as a critical "real asset" for the future economy.

Mawson Infrastructure Group, Inc. engages in the provision of digital asset infrastructure services. The company was founded on February 10, 2012 and is headquartered in Midland, PA.

Mawson Infrastructure Group Inc

Mawson Infrastructure Group is trending due to its recent Nasdaq compliance and a pivotal lawsuit seeking substantial damages from a prior "bad-faith bankruptcy" attempt, signaling potential significant financial recovery. The community is actively discussing an activist investor's growing stake, along with the company's strategic pivot to AI and high-performance computing through its GPU pilot program, reinforcing beliefs of its undervaluation and significant upside.

Velo3D, Inc. operates as a technology company, which engages in developing and manufacturing metal laser sintering printing machines for 3D printing. Its products include assure system, flow software, sapphire printer & sapphire XC. The company was founded by Benyamin Buller in June 2014 and is headquartered in Fremont, CA.

Velo3D Inc

Velo3D is drawing significant attention following a major $32.6 million Department of Defense contract aimed at resolving critical manufacturing bottlenecks and recent $30 million PIPE financing. The community is actively discussing the company's vital role in advanced metal additive manufacturing for aerospace and defense, including its established partnerships with SpaceX and emerging collaborations with defense innovators like Anduril. This positions Velo3D as an essential technology provider for resilient domestic supply chains and next-generation weapons systems.

Taseko Mines Ltd. operates as a mining company which engages in the acquisition, development, and operation of mineral deposits. It holds interest in the Gibraltar, Florence Copper, Aley Niobium, Yellowhead, New Prosperity, and Harmony projects. The company was founded on April 15, 1966 and is headquartered in Vancouver, Canada.

Taseko Mines Ltd.

Taseko Mines is trending due to the imminent production start at its Florence Copper project in Arizona, set to significantly boost output of a critical, low-cost, and environmentally friendly metal within the US. The community is highly focused on Florence's transformative potential and widespread M&A speculation amidst a bullish outlook for copper, driven by global electrification, AI demand, and persistent supply deficits. Despite recent financing activities, investors anticipate substantial future value.

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

ImmunityBio is trending following positive clinical data for its glioblastoma regimen, which demonstrated exceptional patient survival with a "chemo-free" approach, prompting CEO clarification amidst initial investor confusion. The community is energized by ANKTIVA's potential as an immune system "BioShield" across various cancers, highlighted by its first global lung cancer approval in Saudi Arabia. Investors keenly anticipate further updates, including upcoming HPV trial data and details on strategic partnerships, as the market observes significant short interest activity.

PAW Chain has launched the world’s first Layer 3-centric blockchain, enhancing scalability and inter-chain operability across networks. The roadmap features a decentralized exchange, merchant services, and a DAO, all optimized for high-volume, low-cost transactions. Leveraging smart contracts and EVM compatibility, PAW Chain is set to transform digital finance by providing secure, efficient solutions, allowing any project to go multi-chain, underscored by a community-driven governance model and rigorous security standards including regular security audits.

PAW Crypto is gaining traction amidst community discussion surrounding its innovative Layer 3 blockchain architecture, designed to unify liquidity and transactions across numerous chains. Supporters are highly bullish on its advanced infrastructure, which includes enterprise-ready subnets and a refreshed brand identity, aiming for real-world utility and long-term scalability. Many anticipate significant growth as the project prepares for its Q1 2026 network relaunch and expansion of its unified ecosystem.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Definium Therapeutics (NASDAQ:DFTX) Stock Price Expected to Rise, Royal Bank Of Canada Analyst Says

Royal Bank Of Canada lifted their target price on shares of Definium Therapeutics from $20.00 to $36.00 and gave the company an "outperform" rating in a report on Friday...

Definium Therapeutics (NASDAQ:DFTX) Sets New 52-Week High - Here's What Happened

Definium Therapeutics (NASDAQ:DFTX) Reaches New 52-Week High - Here's Why...

Definium Therapeutics Introduces Rerouting Minds, an Educational Campaign Exploring the Potential of Pharmaceutical Lysergide (LSD) in Mental Health Care

Definium Therapeutics, Inc. (formerly Mind Medicine (MindMed) Inc.), a late-stage clinical biopharmaceutical company developing a new generation of therapeutics intended to address underlying causes...

Definium Therapeutics Common Shares to Trade under New Nasdaq Ticker Symbol DFTX Effective January 15, 2026

Definium Therapeutics, Inc. (formerly Mind Medicine (MindMed) Inc.) (the 'Company' or Definium') is updating its previous announcement that the Companys Common Shares would begin trading on Nasdaq...

MindMed Rebrands to Definium Therapeutics, Advancing a Leading Late-Stage Psychiatry Pipeline with Three Phase 3 Readouts Expected in 2026

Definium Therapeutics, Inc. (formerly Mind Medicine (MindMed) Inc.) (the 'Company' or Definium') unveiled its new brand today, marking a decisive step forward as the company leads psychiatry toward a...

$MSFT

$AAPL

$TSLA

$META

Earnings season is heating up, and several major companies report next week, including Microsoft, Apple, Tesla, and Meta. Which are you most excited for?

Which earnings report are you most excited for next week? 
 
Drop a comment for others.

Current Price	$17.22
Prev Close	$16.97
Open	$17.31
Dividend Yield	N/A
50-Day Moving Average	N/A
Beta	N/A
Avg. Volume	N/A
PE Ratio	N/A

52-Week High	N/A
52-Week Low	N/A
Market Capitalization	N/A
EPS (Annual)	N/A
Price to Book	N/A
Revenue Per Employee	N/A
Enterprise Value/EBITDA	N/A

DFTX
Definium Therapeutics Inc.

Feed

News

Sentiment

Fundamentals

Info

Latest DFTX News

DFTXDefinium Therapeutics Inc.